Hormonal contraceptives. Past, present, and future.
D000293:Adolescent; D000328:Adult; D001941:Breast Diseases / Q000517:prevention & control; D001943:Breast Neoplasms / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000139:chemically induced; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D048909:Diabetes Complications; D005260:Female; D005544:Forecasting; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007267:Injections; D008074:Lipoproteins / Q000097:blood; D008525:Medroxyprogesterone / Q000008:administration & dosage; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000517:prevention & control; D012306:Risk; D012907:Smoking; D013924:Thrombophlebitis / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000517:prevention & control
D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D008074:Lipoproteins; D008525:Medroxyprogesterone